stockrowImmatics N.V. (IMTX) vs Oric Pharmaceuticals, Inc. (ORIC)
- Immatics N.V. IMTX 6.34 +2.59%
- Oric Pharmaceuticals, Inc. ORIC 8.80 +3.65%
Immatics N.V. and Oric Pharmaceuticals, Inc. are both Biotechnology companies. Immatics N.V. and Oric Pharmaceuticals, Inc. are of similar size ($924.8M and $880.0M). Oric Pharmaceuticals, Inc. has the higher net margin (0.00% vs −489.4%) and the higher return on invested capital (−83.8% vs −84.8%). Across the 13 metrics below, Oric Pharmaceuticals, Inc. leads on 11 and Immatics N.V. on 2.
Valuation
Profitability
| Metric | IMTX | ORIC | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 0.00% | 68.51% |
| Operating margin | (536.26%) | 0.00% | 0.00% |
| Net margin | (489.35%) | 0.00% | 0.00% |
| Free cash flow margin | (488.01%) | 0.00% | 0.00% |
| Return on equity | (48.53%) | (39.80%) | (51.96%) |
| Return on assets | (39.83%) | (37.35%) | (46.06%) |
| Return on invested capital | (84.83%) | (83.77%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack